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Abstract 1 
Knowledge about the functional status of the frontal cortex in infancy is limited. This study 2 
investigated the effects of polymorphisms in four dopamine system genes on performance in 3 
a task developed to assess such functioning, the Freeze-Frame task, at 9 months of age. 4 
Polymorphisms in the catechol-O-methyltransferase (COMT) and the dopamine D4 receptor 5 
(DRD4) genes are likely to impact directly on the functioning of the frontal cortex, while 6 
polymorphisms in the dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) 7 
genes might influence frontal cortex functioning indirectly via strong fronto-striatal 8 
connections. A significant effect of the COMT Val158Met polymorphism was found. Infants 9 
with the Met/Met genotype were significantly less distractible than infants with the Val/Val 10 
genotype in Freeze-Frame trials presenting an engaging central stimulus. In addition, there 11 
was an interaction with the DAT1 3’ VNTR polymorphism; the COMT effect was only 12 
present in infants who did not have two copies of the DAT1 10-repeat allele. These findings 13 
indicate that dopaminergic polymorphisms already affect selective aspects of attention in 14 
infancy, and further validate the Freeze-Frame task as a frontal cortex task. 15 
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Introduction 4 
The frontal cortex is associated with important cognitive functions such as working 5 
memory and various aspects of cognitive control (for review, see Fuster, 1997; Gazzaley & 6 
D’Esposito, 2007). Despite years of intensive study of this area in adults and non-human 7 
primates, relatively little is known about the functional status of the frontal cortex in infancy. 8 
The frontal cortex has a more protracted development than other areas of the brain, with 9 
synaptogenesis continuing well into middle childhood (Glantz, Gilmore, Hamer, Lieberman, 10 
& Jarskog, 2007; Huttenlocher, 1990). Glucose metabolism and regional cerebral blood flow 11 
also peak later in the frontal cortex (Chugani & Phelps, 1986; Chugani, Phelps, & Mazziotta, 12 
1987; Franceschini et al., 2007). Despite this protracted developmental course, infant 13 
neuroimaging studies have shown activation in the frontal cortex during language processing, 14 
processing of novel stimuli, and working memory (Baird et al., 2002; Bell, 2001; Bell & Fox, 15 
1992, 1997; Dehaene-Lambertz, Dehaene, & Hertz-Pannier, 2002; Homae, Watanabe, 16 
Nakano, & Taga, 2007; Nakano, Watanabe, Homae, & Taga, 2008). Furthermore, Diamond 17 
and colleagues have shown that performance on a task which has been directly associated 18 
with the frontal cortex, the A-not-B task (Piaget, 1954), improves drastically during the 19 
second half of the first year of life (Diamond, 1985; Diamond & Goldman-Rakic, 1989; 20 
Diamond, Zola-Morgan, & Squire, 1989). 21 
A previous report sought to validate a new infant frontal cortex task, the Freeze-Frame 22 
task, by investigating the relationship between this task and other infant and toddler frontal 23 
cortex tasks (Holmboe, Fearon, Csibra, Tucker, & Johnson, 2008). The Freeze-Frame task 24 
was developed to assess various aspects of inhibitory control in infancy using eye movements 25 
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as the dependent measure. In the task, infants are encouraged to stay fixated on an animated 1 
cartoon in the centre of a computer screen. On every trial a peripheral distractor (a white 2 
square) is presented. If the infant looks to this distractor, the animation is frozen for a brief 3 
period of time. Furthermore, the task involves two alternating trial types. In the interesting 4 
trials a dynamic and changeable animation is presented, whereas the boring trials present the 5 
same simple animation (a rotating orange star) every time. 6 
In the study by Holmboe and colleagues (2008) it was found that 9-month-old infants 7 
stopped looking to the distractors during the course of the test session. Infants also looked 8 
less to the distractors in the interesting trials right from the beginning of the session. No 9 
evidence of an interaction between trial type and phase of the test session was found. 10 
Individual performance indices suggested that infants who looked less to the distractors in the 11 
interesting trials than the boring trials early in the Freeze-Frame session performed better on 12 
the A-not-B task at 9 months of age. Another index, which assessed infants’ ability to 13 
selectively learn to inhibit looks to the distractors, was associated with significantly better 14 
performance on a frontal cortex task at 24 months of age, the Spatial Conflict task (Gerardi-15 
Caulton, 2000; Rothbart, Ellis, Rueda, & Posner, 2003), suggesting that Freeze-Frame 16 
performance at 9 months is predictive of later frontal cortex functioning (Holmboe et al., 17 
2008). 18 
Even though these results indicate that performance on the Freeze-Frame task shares a 19 
significant proportion of its variance with performance on other infant and toddler frontal 20 
cortex tasks, this is still relatively indirect evidence that the task depends on the frontal 21 
cortex. More definitive evidence that the task is indeed associated with the functioning of the 22 
frontal cortex would involve establishing a direct relationship between performance on the 23 
task and biological markers of frontal cortex functioning. One way to address this issue is to 24 
investigate the potential effect of genetic variation. In the present study we therefore 25 
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5 
investigated the relationship between performance on the Freeze-Frame task and well-1 
established candidate polymorphisms in dopamine system genes. 2 
The neurotransmitter dopamine plays a major role in the frontal cortex. For example, 3 
depletion of dopamine, but not noradrenaline or serotonin, in the dorsolateral prefrontal 4 
cortex causes delayed-response deficits similar to those seen after ablation of that area 5 
(Brozoski, Brown, Rosvold, & Goldman, 1979; Collins, Roberts, Dias, Everitt, & Robbins, 6 
1998; Roberts et al., 1994). Furthermore, recordings from prefrontal dopamine-sensitive 7 
neurons in primates have shown these neurons to be active during the delay period in 8 
working memory tasks (Goldman-Rakic, Muly, & Williams, 2000; Sawaguchi & Goldman-9 
Rakic, 1991; Vijayraghavan, Wang, Birnbaum, Williams, & Arnsten, 2007). Finally, 10 
Diamond and colleagues investigated children treated early and continuously for 11 
phenylketonuria (PKU) and found that estimated dopamine levels in the frontal cortex 12 
affected children’s performance on frontal cortex tasks throughout infancy and early 13 
childhood (Diamond, Prevor, Callender, & Druin, 1997). 14 
We investigated two dopamine system genes which have been demonstrated to impact on 15 
frontal cortex function in several studies: the catechol-O-methyltransferase (COMT) gene and 16 
the dopamine D4 receptor (DRD4) gene. However, the dopamine system is not restricted to 17 
the frontal cortex. It also plays an important role in subcortical areas such as the striatum. We 18 
therefore included two dopaminergic polymorphisms believed to affect neurotransmission 19 
primarily in the striatum: the TaqIA polymorphism in the dopamine D2 receptor (DRD2) 20 
gene and the 40-bp 3’ VNTR polymorphism in the dopamine transporter (DAT1, SLC6A3) 21 
gene. These polymorphisms could potentially affect performance in the Freeze-Frame task 22 
via frontal-subcortical circuits linking the frontal cortex to distinct areas of the striatum 23 
(Alexander, DeLong, & Strick, 1986; Cummings, 1993; Cummings & Miller, 2007; Di 24 
Martino et al., 2008; Nieoullon, 2002). 25 
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The striatum used to be regarded as a subcortical relay of information from diverse 1 
cortical areas, especially in relation to movement control (reviewed in Alexander et al., 2 
1986). However, Alexander and colleagues (1986) proposed a model whereby distinct basal 3 
ganglia-thalamo-cortical circuits process information relevant to different functional 4 
domains. Two of these circuits involve parts of the prefrontal cortex (the dorsolateral 5 
prefrontal and the lateral orbitofrontal circuits), and one involves the anterior cingulate. In 6 
support of this model, work on experimental animals as well as neuropsychological studies of 7 
human patients have shown deficits in the functions associated with specific frontal areas 8 
(e.g., working memory function associated with the dorsolateral prefrontal cortex) after lesion 9 
of other nodes in the relevant frontal-subcortical circuit (Cummings, 1993; Divac, Rosvold, 10 
& Szwarcbart, 1967; Stuss et al., 1998; Yehene, Meiran, & Soroker, 2008). Furthermore, the 11 
existence of strong functional connections between the striatum and different parts of the 12 
frontal cortex has been confirmed in an analysis of human functional magnetic resonance 13 
imaging (fMRI) data (Di Martino et al., 2008). Given this extensive evidence for frontal-14 
subcortical networks, it seemed important to investigate not just dopamine genes likely to 15 
affect processing in the frontal cortex, but also dopamine genes acting at the subcortical level. 16 
Looking at the individual genes in more detail, the COMT enzyme metabolizes 17 
catecholamines such as dopamine and noradrenaline (Chen et al., 2004; Männistö & 18 
Kaakkola, 1999; Tunbridge, Harrison, & Weinberger, 2006). The role of COMT in 19 
catabolizing dopamine in the frontal cortex is particularly important due to the relative lack of 20 
dopamine transporters and the positioning of these transporters at a distance from synaptic 21 
release sites (Sesack, Hawrylak, Matus, Guido, & Levey, 1998). Thus, COMT accounts for 22 
approximately 50-60% of the metabolic degradation of dopamine in the frontal cortex 23 
(Karoum, Chrapusta, & Egan, 1994; Yavich, Forsberg, Karayiorgou, Gogos, & Männistö, 24 
2007). In contrast, COMT catabolism only plays a minor role in the striatum where the 25 
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dopamine transporter is abundant and better situated for dopamine reuptake (Karoum et al., 1 
1994; Yavich et al., 2007; for review, see Tunbridge et al., 2006). Consistent with this, 2 
studies of COMT-deficient mice have demonstrated increased dopamine availability in the 3 
frontal cortex, but not the striatum (Gogos et al., 1998; Yavich et al., 2007). The important 4 
role of COMT in the cortex compared to the striatum has also recently been shown in vivo in 5 
the human brain using positron emission tomography (PET) (Slifstein et al., 2008). 6 
The Val158Met polymorphism in the COMT gene affects the activity level of the COMT 7 
enzyme. The polymorphism is an evolutionarily recent G (guanine) to A (adenine) missense 8 
mutation at codon 158, resulting in a substitution of methionine (Met) for valine (Val) in the 9 
COMT enzyme (Chen et al., 2004; Lachman et al., 1996; Tunbridge et al., 2006; Tunbridge 10 
et al., 2007). The Val and Met alleles are almost equally frequent in populations of European 11 
descent (Met-allele frequency = .47; heterozygosity = .48), whereas the Val-allele is more 12 
common in other parts of the world (Met-allele frequency = .16-.34; heterozygosity = .27-13 
.45) (Palmatier, Kang, & Kidd, 1999). 14 
The Met variant of the enzyme is less stable at body temperature (Chen et al., 2004; Lotta 15 
et al., 1995), resulting in 3 to 4 times less COMT enzyme activity in the human liver and red 16 
blood cells (Männistö & Kaakkola, 1999). In the human brain this difference is smaller, but 17 
still considerable, with Met/Met homozygotes having approximately 40% less COMT 18 
activity than Val/Val homozygotes in the prefrontal cortex (Chen et al., 2004). The alleles are 19 
codominant, resulting in Val/Met heterozygotes having an intermediate level of COMT 20 
activity (Egan et al., 2001; Männistö & Kaakkola, 1999; Tunbridge et al., 2006). This 21 
evidence strongly suggests that Met/Met homozygotes have the highest baseline level of 22 
dopamine available in the prefrontal cortex (because less dopamine is catabolized) with 23 
Val/Met heterozygotes having an intermediate level, and Val/Val homozygotes having the 24 
lowest level of prefrontal dopamine (Tunbridge et al., 2006; Tunbridge et al., 2007). 25 
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Several studies have demonstrated a relationship between the COMT Val158Met 1 
polymorphism and performance on tasks associated with the frontal cortex. For example, 2 
Egan et al. (2001) found that the COMT Val158Met polymorphism affected performance on 3 
the Wisconsin Card Sorting Test (WCST). Val/Val homozygotes performed significantly 4 
worse than Met/Met homozygotes and heterozygotes. Furthermore, the number of Met-alleles 5 
(0-2) that an individual had significantly predicted neural efficiency in the frontal cortex 6 
during an fMRI task, the N-back task (Egan et al., 2001). In this task all genotype groups 7 
performed at the same level, but Val/Val homozygotes showed significantly greater 8 
activation (indicating lower neural efficiency) in the frontal cortex than heterozygotes, and 9 
heterozygotes showed significantly greater activation than Met/Met homozygotes. Recent 10 
meta-analyses have been inconsistent in terms of the relationship between performance on the 11 
WCST and the COMT Val158Met polymorphism (Barnett, Jones, Robbins, & Müller, 2007; 12 
Barnett, Scoriels, & Munafò, 2008). However, the evidence for an effect on neural efficiency 13 
as well as on a range of frontal cortex tasks has been replicated in several studies (Bertolino 14 
et al., 2006; Blasi et al., 2005; Caldú et al., 2007; Diaz-Asper et al., 2008; Krämer et al., 15 
2007; Mattay et al., 2003; Meyer-Lindenberg et al., 2006; Sheldrick et al., 2008; Stefanis et 16 
al., 2005), and has recently been extended to a mouse model of the Val158Met polymorphism 17 
(Papaleo et al., 2008). Finally, a study by Diamond and colleagues (2004) demonstrated an 18 
effect of the COMT Val158Met polymorphism on school-age children’s performance on a task 19 
hypothesized to depend on dopamine in the prefrontal cortex. This finding demonstrates the 20 
potential effect of variation in COMT activity at younger ages, and opens up the possibility 21 
that the COMT Val158Met polymorphism might have an effect on frontal cortex functioning 22 
already in infancy. 23 
The second candidate gene in our study was the DRD4 gene. Knowledge about the 24 
distribution of the D4 receptor in the human brain is limited due to the lack of appropriate 25 
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radioligands (Hurd & Hall, 2005; Oak, Oldenhof, & Van Tol, 2000). However, existing 1 
evidence suggests that D4 receptors are most abundant in the retina, followed by the 2 
prefrontal cortex (Oak et al., 2000). Hurd and Hall (2005) suggest that transmission via D4 3 
receptors is predominantly inhibitory in nature, resulting in disinhibition of excitatory 4 
transmission when these receptors are blocked (Hurd & Hall, 2005). Thus, a lack of or less 5 
efficient D4 receptors may lead to deficits in frontal cortex functioning. 6 
The most widely studied polymorphism of the DRD4 gene is located in the third exon 7 
and contains a 48 base pair variable number of tandem repeats (48-bp VNTR). Nine alleles of 8 
the DRD4 48-bp VNTR have been identified world-wide, with the number of repeats ranging 9 
between 2 and 10. The 4- and 7-repeat alleles are the most common globally, though the 2-10 
repeat allele is prevalent in South and East Asia. In a population of mixed European ancestry, 11 
allele frequencies are .57, .21 and .12 for the 4-, 7- and 2-repeat alleles respectively (Chang, 12 
Kidd, Livak, Pakstis, & Kidd, 1996). 13 
The number of 48-bp repeats has been hypothesized to affect the transmitted signal in the 14 
postsynaptic neuron. However, findings from in vitro studies have shown that the DRD4 48-15 
bp VNTR does not significantly alter D4 receptor activity (Oak et al., 2000). A more recent 16 
study suggests that the different repeat sequences may affect gene expression differentially, 17 
i.e., the density of D4 receptors in the brain. This study found that the 7-repeat allele had 18 
reduced expression compared to the 2-repeat and 4-repeat alleles (Schoots & Van Tol, 2003). 19 
The DRD4 48-bp VNTR has been extensively studied in relation to Attention Deficit 20 
Hyperactivity Disorder (ADHD) (Li, Sham, Owen, & He, 2006). ADHD has been linked to 21 
performance deficits on tasks assessing frontal cortex functions such as response inhibition, 22 
selective attention and set shifting (for review, see Cornish et al., 2005). The 7-repeat allele 23 
has been consistently associated with ADHD in recent meta-analyses (Faraone et al., 2005; Li 24 
et al., 2006). Furthermore, the DRD4 48-bp VNTR has been shown to affect prefrontal grey 25 
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matter volume in a sample of boys diagnosed with ADHD, their siblings and controls 1 
(Durston et al., 2005). Recently, the 7-repeat allele has also been found to be associated with 2 
impulsivity and lower levels of response inhibition in healthy adults, both on its own 3 
(Congdon, Lesch, & Canli, 2008) and in combination with other polymorphisms in dopamine 4 
system genes (Congdon et al., 2008; Eisenberg et al., 2007). Finally, the 7-repeat allele has 5 
been linked to faster habituation in infancy and increased novelty seeking in adolescence 6 
(Laucht, Becker, & Schmidt, 2006), and to sensation seeking in toddlers when combined with 7 
poor parenting (Sheese, Voelker, Rothbart, & Posner, 2007). Therefore, the DRD4 48-bp 8 
VNTR can be considered a candidate polymorphism for frontal cortex functioning in infancy. 9 
Turning to the genes most likely to act at the subcortical level, the D2 receptor is 10 
considerably less prevalent in the cerebral cortex than in the striatum (Ito, Okubo, Halldin, & 11 
Farde, 1999; Lidow, Goldman-Rakic, Rakic, & Innis, 1989). The DRD2 TaqIA 12 
polymorphism is located in the 3’ untranslated region, 10 kb downstream from the DRD2 13 
gene, actually in the adjacent gene ANKK1 (Neville, Johnstone, & Walton, 2004). A1 is the 14 
minor allele. The A1-present (A1+) genotype has a prevalence of approximately 31% in 15 
Caucasian individuals (Noble, 2000). The presence of this allele has been associated with 16 
lower D2 receptor density in the human brain using PET, especially in the striatum (Jönsson 17 
et al., 1999; Pohjalainen et al., 1998; Ritchie & Noble, 2003; Thompson et al., 1997). 18 
In contrast to the DRD4 48-bp VNTR, the DRD2 TaqIA polymorphism is not associated 19 
with ADHD (Faraone et al., 2005). However, the A1 allele has been associated with various 20 
addictions (Munafò, Matheson, & Flint, 2007; Young, Lawford, Nutting, & Noble, 2004) and 21 
a more impulsive response style in a monetary reward task in healthy adults (Eisenberg et al., 22 
2007). Little evidence exists for a role of the DRD2 TaqIA polymorphism in frontal cortex 23 
functioning. However, Reuter and colleagues (2005) showed a significant interaction between 24 
the DRD2 TaqIA polymorphism and the COMT Val158Met polymorphism on a Stroop-like 25 
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task where participants had to respond to the written form of color words written in 1 
incongruent colors as quickly as possible. The interaction effect accounted for 13% of the 2 
variance in performance on this task. This result opens up the possibility that the DRD2 gene 3 
(and perhaps other subcortical dopaminergic genes) impacts indirectly on frontal cortex 4 
functioning via interactions with genes affecting dopaminergic neurotransmission directly in 5 
the frontal cortex (e.g., COMT and DRD4). 6 
Finally, we investigated the potential effect of a well-known polymorphism of the 7 
dopamine transporter (DAT1) gene. The dopamine transporter is primarily expressed in the 8 
mesencephalon (a subcortical area with strong dopaminergic projections to the striatum and 9 
frontal cortex), with the highest density in the basal ganglia (Hurd & Hall, 2005). The DAT1 10 
gene contains a 40-bp VNTR in the 3’ untranslated region. Alleles range from 3 to 13 repeats, 11 
but the most common are the 9-repeat and 10-repeat alleles (Cornish et al., 2005). In 12 
populations of European ancestry the frequencies of the 9- and 10-repeat alleles vary, but 13 
most studies report frequencies of approximately .30 for the 9-repeat allele and .70 for the 10-14 
repeat allele (Kang, Palmatier, & Kidd, 1999). Although analyses of mRNA levels in brain 15 
regions resulted in contradictory findings (Mill, Asherson, Browes, D'Souza, & Craig, 2002; 16 
Wonodi et al., 2009), two independent large-scale in vivo single photon emission computed 17 
tomography (SPECT) studies have shown that healthy individuals with at least one copy of 18 
the 9-repeat allele (9/9 and 9/10 genotypes) had higher transporter density, and therefore 19 
presumably more effective dopamine removal at the synapse, than the 10/10 genotype (van 20 
de Giessen et al., 2008; van Dyck et al., 2005). 21 
In terms of phenotypes, the DAT1 gene has been studied extensively in relation to ADHD 22 
because stimulant medication used in its treatment acts by blocking the dopamine transporter. 23 
Evidence suggests that 10/10 homozygosity is associated with a slightly increased risk of 24 
ADHD (Faraone et al., 2005). Furthermore, Cornish and colleagues (2005) reported an 25 
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association between the 10/10 genotype and ADHD symptoms in a general population 1 
sample. This group also found an independent association between the 10/10 genotype and 2 
poorer performance on measures of selective attention and response inhibition in their 3 
selected high- and low-risk sample. A similar trend was found by Congdon and colleagues 4 
(2008) in a sample of healthy adults. Despite these findings, recent neuroimaging studies in 5 
adults have indicated a more efficient neural response in the prefrontal cortex of 10/10 6 
homozygotes during a working memory task (Bertolino et al., 2006; Caldú et al., 2007), a 7 
pattern similar to that which is seen in subjects with the COMT Met/Met genotype. One 8 
recent study also found higher levels of impulsivity in healthy adults with at least one 9-9 
repeat allele (Forbes et al., 2007), contradicting other behavioral results. The behavioral 10 
effects of the DAT1 3’ VNTR polymorphism may depend on the population studied. 11 
In summary, the present study investigated whether performance on the Freeze-Frame 12 
task at 9 months of age was associated with genetic polymorphisms affecting important 13 
aspects of dopamine function in the brain. Since dopamine plays an important role in both the 14 
frontal cortex and the striatum, direct effects of the COMT Val158Met and DRD4 48-bp 15 
VNTR were hypothesized, with potential interacting or indirect effects of the DRD2 TaqIA 16 
and the DAT1 3’ VNTR polymorphisms. 17 
Methods 18 
Sample 19 
Infants were recruited from the greater London area. Data from two independent cohorts 20 
of infants were combined in the present study. Cohort 1 consisted of a small group of infants 21 
(N = 24). Behavioral results from this cohort have been reported previously (Holmboe et al., 22 
2008). Cohort 2 consisted of a considerably larger group of infants (N = 104) who took part 23 
in a longitudinal study of frontal cortex functioning during the first year of life. Ninety-four 24 
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infants from the original cohort of 104 infants (recruited at 4 months) participated in the 1 
study at 9 months. Data from this cohort have not been reported previously. 2 
Data on parental education and household income were only collected in Cohort 2, but 3 
generally represent families recruited for studies at our laboratory. Parents were in their mid-4 
thirties (mothers: M = 34.43, SD = 4.90; fathers: M = 36.45, SD = 6.61) and primarily, but not 5 
exclusively, of middle or upper-middle class socio-economic status (maternal years of 6 
education: M = 17.80, SD = 3.55; household income in £: M = 65,076, SD = 61,8541). 7 
Seventy-nine percent of the infants tested (Cohorts 1 and 2 combined) had a White/Caucasian 8 
ethnic background (approx. ¾ of these infants were of British or Irish descent), and 21% had 9 
other or mixed ethnic background. Of the infants with other than Caucasian ethnic 10 
background (N = 26), 8% of infants had an Asian ethnic background, 15% had a Black ethnic 11 
background, and 77% had a mixed ethnic background (e.g., mother Asian and father 12 
Caucasian). Ethical permission for the study was obtained from the School of Psychology 13 
ethics board at Birkbeck, University of London. 14 
The Freeze-Frame task 15 
A detailed description of the Freeze-Frame task can be found in Holmboe et al. (2008). In 16 
short, infants were presented with animations in the centre of a 19-inch color monitor. Infants 17 
were seated in their parent’s lap at a 60-cm distance from the monitor. On every trial a white 18 
square was flashed on the right or left side of the screen (the distractor). If the infant looked 19 
to the distractor, the animation was stopped for 3000 ms. If the infant did not look to the 20 
distractor, the animation continued after distractor presentation for the duration of the trial. 21 
Distractor duration was calibrated individually for each infant by increasing it by 40 ms on 22 
                                                 
1 Approximate US$ equivalent: M = 120,511, SD = 114,544, based on the average GB£ per US$ exchange rate 
of 0.54 in 2006 (NationMaster.com, 2009) when the majority of the data was collected. 
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every trial where the infant did not look to the distractor. When the infant had looked to the 1 
distractor on two consecutive trials, distractor duration was fixed at the current duration for 2 
the rest of the test session. The even-numbered trials presented dynamic and colorful 3 
animations changing every 2 s (interesting trials), whereas the odd-numbered trials always 4 
presented the same uninteresting rotating orange star (boring trials). Infants were encouraged 5 
to complete 60 trials. 6 
A few minor adjustments were made to the task used in Cohort 2. Most importantly, the 7 
animations were slightly smaller and a different set of animations was used for the interesting 8 
trials. The procedure used in Cohort 2 was the same as the procedure used in Cohort 1. In the 9 
new version distractor duration did not increase beyond 1200 ms. Infants were encouraged to 10 
complete 80 trials. The data were analyzed as described in Holmboe et al. (2008). That is, the 11 
session was divided into phases (from two trials before the calibration trial), invalid trials 12 
were excluded, and the proportion of looks to the distractors was calculated separately for 13 
boring and interesting trials in each phase. However, the additional data collection allowed an 14 
extra phase in the analyses. Thus, there were 4 phases of the experiment, each containing 16 15 
trials (8 boring and 8 interesting). 16 
Video recordings of each infant’s behavior were coded offline. The coding procedure in 17 
Cohort 2 was similar to the procedure reported in Holmboe et al. (2008). The trial was 18 
considered invalid if the infant was not looking at the central stimulus at distractor onset. The 19 
trial was also considered invalid if the infant blinked (i.e., the pupils were fully covered) 20 
during distractor presentation. In addition, the trial was considered invalid if these behaviors 21 
occurred during the 1000 ms following distractor presentation. This criterion was added 22 
because in trials where the infant looks away immediately following distractor presentation, it 23 
is impossible to know whether the infant would have looked to the distractor if they had not 24 
looked away from the screen. On rare occasions, a trial was excluded because the infant’s 25 
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eyes were out of view (e.g., if the infant’s hand was in front of his or her eyes); such trials 1 
were considered invalid if the eyes were out of view for more than 2 frames (80 ms) during 2 
distractor presentation or within the 1000 ms following distractor presentation. Finally, trials 3 
where a saccade to the distractor was initiated earlier than 3 frames (120 ms) after distractor 4 
onset were also considered invalid; such saccades were most likely anticipatory or random. 5 
Inter-coder reliability in Cohort 2 was satisfactory for both looking behavior (κ = .94) and 6 
trial validity (κ = .86), based on data from 10 participants. (Inter-coder reliability in Cohort 1 7 
was similar; see Holmboe et al., 2008.) 8 
Collection of buccal swabs and DNA extraction 9 
Buccal (cheek) swabs were collected at 3.5 years of age in Cohort 1 as part of a follow-10 
up study, and at 4 months in Cohort 2. The buccal swab was collected by the parent in the lab 11 
(by rubbing the cotton bud on the inside of the child’s cheeks for approximately 5-10 12 
seconds), and then put in a sample tube by the experimenter. Two swabs per DNA sample 13 
tube were collected, and two independent samples per infant were shipped and isolated 14 
separately using a DNA-purification kit obtained from Gentra (Minneapolis, US), yielding 15 
total of 2-10 µg DNA per sample. 16 
Genotyping 17 
Genotyping procedures were carried out using published protocols (DRD2 TaqIA: 18 
Grandy, Zhang, & Civelli, 1993; DRD4 48-bp VNTR: Ronai et al., 2000; COMT Val158Met: 19 
Tarnok et al., 2007; DAT1 3’ VNTR: Vandenbergh et al., 1992). Both DNA samples from 20 
each infant were genotyped for all the investigated polymorphisms. In order to ensure 21 
successful genotyping, the following precautions were taken: In case of unsuccessful 22 
amplification (~10%) at the DRD4 and DAT1 VNTR genotyping, the PCR reaction was 23 
repeated, hence the genotyping success rate was 100%. In addition, independent 24 
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amplification reactions were carried out for 50% of the samples at the DRD4 VNTR, because 1 
of the problematic amplification of the longer alleles (Ronai et al., 2000), this quality 2 
checkup yielded the same genotypes as the ones originally obtained. At the DRD2 TaqI 3 
restriction enzyme digestion genotyping was repeated in case of unsuccessful amplification 4 
(~5%) or non-identical results for the two samples (~8%). The COMT Val158Met SNP 5 
(rs4680) was also genotyped by an alternative method using a pre-designed TaqMan kit 6 
(C_25746809_50, Applied BioSystem, Foster City, USA) on a 7300 Real-Time PCR System; 7 
the genotypes were in accordance with the original ones. 8 
Data analyses 9 
Behavioral data were analyzed using repeated measures analysis of variance (ANOVA). 10 
For the genotype analyses, data were analyzed using a Linear Mixed Model analysis (LMM) 11 
assuming a diagonal covariance structure. Phase and Trial Type were entered as repeated 12 
measures and proportion of looks to the distractors was entered as the dependent measure. 13 
The advantage of LMM is that data from participants with missing data points, in this case 14 
missing data from one or more phases of the experiment, can be included in the analysis 15 
(Garson, 2008). Missing data points are inevitable in infant studies, and, given the fact that 16 
the genotype effects we were interested in were likely to be modest in magnitude, we wished 17 
to include as much of the data in the analyses as possible. 18 
Due to the risk of population stratification in ethnically mixed samples (Hutchison, 19 
Stallings, McGeary, & Bryan, 2004), genotype analyses were carried out on both the entire 20 
sample and on the subsample of infants of Caucasian ethnic origin. Significant main effects 21 
and interactions were followed up by posthoc tests and checked against a False Discovery 22 
Rate (FDR) adjusted p-value based on the total number of posthoc tests carried out across all 23 
genotype analyses in both the total sample and the Caucasian subsample (33 posthoc tests in 24 
total). The FDR was controlled at p < .05 using the method described by Benjamini et al. 25 
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(2001). Only posthoc comparisons that remained significant after controlling the FDR are 1 
reported. 2 
The Hardy-Weinberg (HW) equilibrium test was calculated using Knud Christensen’s 3 
program (Christensen, 1999); for the DAT1 3’ VNTR the three common genotypes from two 4 
frequent alleles (9- and 10-repeat) were included in the analysis, and for the DRD4 48-bp 5 
VNTR, genotypes from 4 common alleles (2-, 3-, 4-, 7-repeat) were analyzed. For the COMT 6 
Val158Met and DRD2 TaqIA polymorphisms there were only 3 genotypes, and therefore all 7 
infants could be included in the HW test. 8 
In the analyses investigating potential genotype effects on Freeze-Frame performance, 9 
the most frequent 10/10 genotype of the DAT1 3’ VNTR was compared to all other genotypes 10 
(9/9, 9/10 and other types of heterozygotes, i.e., 3/10, 7/10, 10/11). The latter group is 11 
referred to as the non-10/10 group. Genotype grouping for the DRD4 48-bp VNTR 12 
polymorphism was based on the presence or absence of the 7-repeat allele (the 7+ group and 13 
the 7- group, respectively). One infant with the genotype 4/8 was included in the 7+ group. 14 
Results 15 
Genotype and allele distribution 16 
Genotype data were available for 19 out of the 24 infants in Cohort 1. Seventeen of these 17 
infants were of Caucasian ethnic origin. In Cohort 2 genotype data were available for all 94 18 
infants (71 Caucasian) tested at 9 months of age. When the two cohorts were pooled, 19 
genotype data were available for 113 infants (88 Caucasian). One hundred and two of these 20 
infants calibrated in the task (see below) and could be included in the analyses. Genotype 21 
frequencies for each of the four polymorphisms are presented in Table 1, and allele 22 
frequencies are presented in the Supplementary Table. Alleles and genotypes were in Hardy-23 
Weinberg equilibrium for all polymorphisms, with the exception of the DRD4 48-bp VNTR 24 
DOPAMINE GENES AND INFANT ATTENTION 
 
 
18 
polymorphism in the total sample (see note to Table 1). When the Hardy-Weinberg analysis 1 
of the DRD4 48-bp VNTR was restricted to the Caucasian subsample, the p-value increased 2 
to .45. In order to ensure a genetically homogenous population, every genetic analysis was 3 
carried out in the Caucasian subsample as well. Allele and genotype frequencies were 4 
generally in agreement with the frequencies reported for a mixed European population (see 5 
Introduction), and were very similar in the total sample and the Caucasian subsample. 6 
Freeze-Frame behavioral results 7 
One hundred and two infants out of the 113 infants with genotype data available 8 
calibrated in the Freeze-Frame task (79 in the Caucasian subsample), i.e. they looked to the 9 
distractor on two consecutive trials (6 infants did not calibrate, and 5 infants were incorrectly 10 
calibrated by the experimenter; these infants could not be included in the analyses). Distractor 11 
duration was on average calibrated in 5.53 trials (SD = 8.13, ranging from 2 to 64), and the 12 
mean calibrated distractor duration was 324 ms (SD = 181, ranging from 200 to 1200). The 13 
average proportion of valid trials was .82 (SD = .10). Infants in Cohort 2 had a slightly lower 14 
proportion of valid trials than infants in Cohort 1 (.81 vs. .90), probably due to the session 15 
being a few minutes longer in the former cohort, but the groups did not differ significantly in 16 
terms of calibration data (data not shown). 17 
The proportion of looks to the distractors in each phase and trial type is presented in 18 
Table 2. Freeze-Frame results from Cohort 1 have been reported previously (Holmboe et al., 19 
2008). In the previous study a repeated measures ANOVA indicated that there were 20 
significant main effects of Phase and Trial Type, but no interaction. Results were unchanged 21 
in the sample of infants from Cohort 1 for whom genotype data were available (data not 22 
shown). These results were also replicated in Cohort 2 (Trial Type: F(1,68) = 79.29, p < .001, 23 
 = .54; Phase: F(2,136) = 99.63, p < .001,  = .59; Phase × Trial Type: F(2,136) = 0.63, p 24 
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= .53), and in the total sample (Trial Type: F(1,81) = 105.99, p < .001,  = .57; Phase: 1 
F(2,162) = 117.42, p < .001,  = .59; Phase × Trial Type: F(2,162) = 0.59, p = .55). The 2 
same significant effects were found when 4 phases were included in the ANOVA of data 3 
from Cohort 2 (data not shown). These results indicate that there is a clear main effect of 4 
Trial Type on looks to the distractors such that infants look less to the distractors in the 5 
interesting trials than in the boring trials. Infants also show a decrease in looks to the 6 
distractors during the test session, and this decrease is similar in the two trial types, i.e., no 7 
interaction (Table 2). 8 
For the genotype analyses we wished to combine the data from the two cohorts to 9 
increase power. In order to combine all the available data, it was important to establish that 10 
infants in the two cohorts performed the task in the same way. A few minor parameters of the 11 
Freeze-Frame task differed between the two cohorts (see Methods). Therefore, the repeated 12 
measures ANOVA was repeated with Cohort as a between-subjects factor. This analysis 13 
clearly replicated the main effects and lack of interaction (data not shown). Importantly, there 14 
was no significant main effect of, or interactions involving, Cohort (all ps > .30). Given this 15 
lack of significant differences between the two cohorts, it was deemed appropriate to pool the 16 
data for the genotype analyses. 17 
In all of the genotype analyses reported below the main effects of Phase and Trial Type 18 
remained highly significant with no interaction between Phase and Trial Type (data not 19 
shown). Furthermore, none of the polymorphisms was associated with basic task parameters 20 
such as the calibrated distractor duration or proportion of valid trials after controlling the 21 
FDR. 22 
The COMT Val158Met polymorphism and Freeze-Frame performance 23 
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All 4 phases of the Freeze-Frame task were included in the LMM since this analysis 1 
incorporates all available data. The LMM analysis indicated that there was a significant main 2 
effect of COMT Val158Met Genotype on the proportion of looks to the distractors, 3 
F(2,564.08) = 3.01, p < .050. No interactions involving COMT Val158Met Genotype reached 4 
significance in the total sample (all ps > .15). When the analysis was restricted to Caucasian 5 
infants this picture changed. The main effect of COMT Val158Met Genotype was no longer 6 
significant, F(2,418.32) = 2.20, p = .112), but the COMT Val158Met Genotype × Trial Type 7 
interaction was, F(2,418.32) = 4.38, p = .013, indicating that COMT Val158Met Genotype 8 
affected performance in the two trial types differentially. No other interactions approached 9 
significance (all ps > .70).  10 
Post hoc analyses on the main effect of COMT Val158Met Genotype in the total sample 11 
indicated that none of the differences between genotype groups survived the FDR correction. 12 
Post hoc analyses of the COMT Val158Met Genotype × Trial Type interaction observed in the 13 
Caucasian subsample indicated a significant difference in looks to the distractors in 14 
interesting trials both between the Met/Met and Val/Val group (p < .0001) and between the 15 
Met/Met and Val/Met group (p < .01). No other posthoc comparisons reached significance 16 
after controlling the FDR. The COMT Val158Met genotype differences in the Caucasian 17 
subsample are illustrated in Figure 1a. 18 
The DRD4 48-bp VNTR polymorphism and Freeze-Frame performance 19 
The LMM analysis of the effect of the DRD4 48-bp VNTR on performance in the 20 
Freeze-Frame task showed no significant effects involving Genotype in either the total or the 21 
Caucasian subsample (all ps > .15). This indicates that, in the current sample, the 7+ group 22 
did not differ from the 7- group in terms of Freeze-Frame performance at 9 months of age. 23 
The DRD2 TaqIA polymorphism and Freeze-Frame performance 24 
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The LMM showed no significant effects involving DRD2 TaqIA Genotype (all ps > .70). 1 
This result was unchanged when the analysis was restricted to Caucasian infants (all ps > 2 
.20). The DRD2 TaqIA polymorphism did not therefore have any significant effect on 3 
Freeze-Frame performance in the present sample. 4 
The DAT1 3’ VNTR polymorphism and Freeze-Frame performance 5 
The LMM analysis of the DAT1 3’ VNTR showed a significant main effect of Genotype 6 
in the total sample, F(1,569.52) = 3.98, p = .047. No interactions reached significance (all ps 7 
> .15). When the analysis was restricted to Caucasian infants, the main effect of DAT1 3’ 8 
VNTR Genotype was only marginally significant, F(1,427.74) = 2.92, p = .088. There was 9 
also a marginally significant DAT1 3’ VNTR Genotype × Phase interaction, F(3,191.66) = 10 
2.34, p = .075. The main effect of DAT1 3’ VNTR Genotype in the total sample was due to 11 
the 10/10 group looking less to the distractors overall than the non-10/10 group. This 12 
difference is illustrated in Figure 1b. No posthoc analyses were carried out since only the 13 
main effect of DAT1 3’ VNTR Genotype was significant. 14 
Analysis of the combined effect of the COMT Val158Met and DAT1 3’ VNTR polymorphisms 15 
on Freeze-Frame performance 16 
The genotype distribution of the COMT Val158Met and DAT1 3’ VNTR, with genotype × 17 
genotype group sizes between 9 and 26 participants (see legend to Figure 1), allowed us to 18 
investigate the potential interaction between these two polymorphisms. (Genotype 19 
frequencies for the other polymorphisms investigated in the study resulted in group sizes that 20 
were too small to investigate interactions, with n for minor genotype × genotype groups being 21 
less than 5.) An LMM where both DAT1 3’ VNTR Genotype and COMT Val158Met 22 
Genotype were entered as independent variables showed a significant main effect of COMT 23 
Val158Met Genotype, F(2,528.98) = 3.41, p = .034, and a marginally significant effect of 24 
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DAT1 3’ VNTR Genotype, F(1,529.47) = 3.30, p = .070. In addition to these main effects, 1 
there was a significant COMT Val158Met Genotype × Trial Type interaction, F(2,528.98) = 2 
3.19, p = .042, and a significant DAT1 3’ VNTR Genotype × COMT Val158Met Genotype × 3 
Trial Type interaction, F(2,528.98) = 4.09, p = .017. The DAT1 3’ VNTR Genotype × Phase 4 
interaction approached significance, F(3,240.18) = 2.24, p = .084, as did the DAT1 3’ VNTR 5 
Genotype × COMT Val158Met Genotype × Phase interaction, F(6,241.10) = 1.91, p = .079. 6 
No other interactions approached significance in the total sample (all ps > .35). 7 
In the Caucasian subsample alone the results were slightly different. The main effect of 8 
COMT Val158Met Genotype was marginally significant, F(2,373.00) = 2.82, p = .061. The 9 
same was the case for the DAT1 3’ VNTR Genotype, F(1,374.07) = 3.82, p = .051. Again, the 10 
COMT Val158Met Genotype × Trial Type interaction was significant, F(2,373.00) = 4.13, p = 11 
.017. Finally, the DAT1 3’ VNTR Genotype × Phase interaction was significant in the 12 
Caucasian subsample, F(3,170.63) = 2.98, p = .033. No other interactions reached 13 
significance in the Caucasian subsample (all ps > .20). 14 
Post hoc analyses were restricted to the novel interaction effects involving COMT 15 
Val158Met and DAT1 3’ VNTR because all significant and near-significant main effects were 16 
qualified by a significant interaction, and because other interactions, such as the COMT 17 
Val158Met Genotype × Trial Type interaction, essentially indicated the same genotype effects 18 
as the analyses of the two polymorphisms separately. Posthoc analyses of the DAT1 3’ VNTR 19 
Genotype × COMT Val158Met Genotype × Trial Type interaction in the total sample indicated 20 
that within the DAT1 non-10/10 group there was a significant difference in looks to the 21 
distractors in the interesting trials between the Met/Met and Val/Val groups (p < .001) and 22 
between the Met/Met and Val/Met groups (p = .001). In contrast, no COMT genotype 23 
differences reached significance in the DAT1 10/10 group after controlling the FDR. This 24 
pattern of results is illustrated in Figure 1c. Regarding performance in each COMT genotype 25 
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group across DAT1 genotypes, infants with the Val/Met genotype who also had the DAT1 1 
10/10 genotype looked significantly less to the distractors in the interesting trials than infants 2 
with the Val/Met genotype in the DAT1 non-10/10 group (p < .01). The other COMT 3 
genotype groups did not differ significantly across DAT1 genotype groups in the interesting 4 
trials (Figure 1c). None of the posthoc tests of the DAT1 3’ VNTR Genotype × COMT 5 
Val158Met Genotype × Trial Type interaction showed significant effects in the boring trials 6 
after controlling the FDR. 7 
Posthoc analyses indicated that the DAT1 3’ VNTR Genotype × Phase interaction found 8 
in the Caucasian subsample was due to a highly significant difference in proportion of looks 9 
to the distractors between the 10/10 group and the non-10/10 group in Phase 3 of the Freeze-10 
Frame session (p < .001). 11 
Discussion 12 
The present study investigated whether performance in a novel task developed to assess 13 
frontal cortex functioning in infancy, the Freeze-Frame task (Holmboe et al., 2008), was 14 
associated with common polymorphisms in four dopamine system genes. Previous research 15 
has clearly shown that dopamine plays an important role in the frontal cortex (Brozoski et al., 16 
1979; Collins et al., 1998; Diamond et al., 1997; Goldman-Rakic et al., 2000; Roberts et al., 17 
1994; Sawaguchi & Goldman-Rakic, 1991; Vijayraghavan et al., 2007). 18 
Behaviorally, we replicated previous findings on the Freeze-Frame task (Holmboe et al., 19 
2008). In relation to the polymorphisms likely to impact directly on frontal cortex function, 20 
we found a significant association between Freeze-Frame performance and the COMT 21 
Val158Met polymorphism. Given the extensive evidence for an association between the 22 
COMT Val158Met polymorphism and performance on a range of frontal cortex tasks 23 
(Diamond et al., 2004; Diaz-Asper et al., 2008; Egan et al., 2001; Mattay et al., 2003; 24 
Sheldrick et al., 2008; Stefanis et al., 2005; see also Papaleo et al., 2008), as well as effects 25 
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on neural efficiency in the frontal cortex during performance of these tasks (Bertolino et al., 1 
2006; Blasi et al., 2005; Caldú et al., 2007; Egan et al., 2001; Krämer et al., 2007; Mattay et 2 
al., 2003; Meyer-Lindenberg et al., 2006), it seems likely that COMT Val158Met genotype 3 
affects dopamine levels in the frontal cortex and thereby Freeze-Frame task performance in 4 
our infant sample. 5 
Furthermore, it is worth noting that this effect was specific to the interesting trials, at 6 
least in the Caucasian subsample (Figure 1a). This suggests that the COMT Val158Met effect 7 
is not a general effect impacting on infants’ distractibility level in any given situation. Rather, 8 
it seems to be the case that infants with the low-enzyme activity Met/Met genotype became 9 
particularly focused on the central stimulus compared to the high-enzyme activity Val/Val 10 
genotype when this stimulus was engaging. However, it should be noted that the interaction 11 
with trial type was significant in the Caucasian subsample only and therefore might not 12 
generalize to other populations. 13 
We found little evidence that the DRD4 48-bp VNTR polymorphism affects performance 14 
on the Freeze-Frame task at 9 months of age, though the sample was too small to detect 15 
subtle effects. In terms of the polymorphisms which are likely to act in the striatum, we did 16 
not observe any effect of the DRD2 TaqIA either. We did however observe an effect of the 17 
DAT1 3’ VNTR polymorphism. In contrast to the effect of the COMT Val158Met 18 
polymorphism, this effect did not appear to be specific to a particular trial type. Instead, we 19 
found evidence of an overall difference in the proportion of looks to the distractors with the 20 
10/10 group looking less to the distractors than the non-10/10 group (Figure 1b). The results 21 
therefore suggest that the DAT1 3’ VNTR polymorphism modulates overall distractibility in 22 
the Freeze-Frame task, though there was a tendency for this genotype effect to be stronger at 23 
the end of the test session. Given the fact that the dopamine transporter plays an important 24 
role in the striatum (Hurd & Hall, 2005; Karoum et al., 1994), this effect could be due to 25 
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modulation of general attentional mechanisms mediated by the subcortical dopamine system 1 
or frontal-subcortical connections (Alexander et al., 1986; Cummings, 1993). 2 
Finally, we investigated the potential interaction between the COMT Val158Met and 3 
DAT1 3’ VNTR polymorphisms on Freeze-Frame performance. The results of these analyses 4 
broadly replicated the main effects and interactions found in the analysis of each 5 
polymorphism separately. However, the analyses also revealed a significant DAT1 3’ VNTR 6 
Genotype × COMT Val158Met Genotype × Trial Type interaction, suggesting that the DAT1 7 
3’ VNTR polymorphism modulated the effect of the COMT Val158Met polymorphism on 8 
Freeze-Frame performance. Basically, the effect of the COMT Val158Met polymorphism on 9 
the proportion of looks to the distractors in the interesting trials was strong in the DAT1 non-10 
10/10 group, with particularly large differences between the Met/Met group and the two other 11 
genotype groups (Figure 1c, right panel). In contrast, the equivalent effect in the DAT1 10/10 12 
group virtually disappeared (Figure 1c, left panel). 13 
Presuming that a lower level of distractibility in the interesting trials is an expression of a 14 
higher degree of selective inhibition, these results suggest that infants with the higher COMT 15 
enzyme activity alleles (Val/Val and Val/Met) actually benefit from having the DAT1 10/10 16 
genotype, whereas this is not the case for infants with the low-activity enzyme (Met/Met). 17 
This was confirmed at least for the Val/Met genotype; this genotype showed a significant 18 
reduction in looks to the distractors in the interesting trials when combined with the 10/10 19 
genotype rather than with the non-10/10 genotype (Figure 1c). Though preliminary given the 20 
sample size, these findings are particularly interesting because they suggest that the 21 
interaction between a predominantly frontal dopaminergic polymorphism (COMT Val158Met) 22 
and a predominantly striatal dopaminergic polymorphism (DAT1 3’ VNTR) results in large 23 
performance differences on the Freeze-Frame task already at 9 months. 24 
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It should be mentioned that it would have been ideal to investigate all possible 1 
interactions between the four polymorphisms in the study. However, only the COMT 2 
Val158Met and the DAT1 3’ VNTR polymorphisms had genotype frequencies providing 3 
enough power to investigate interaction effects (see Methods). For the DRD4 48-bp VNTR 4 
and the DRD2 TaqIA polymorphisms the genotype frequencies involving the minor allele 5 
were too low to test meaningful interactions. Future studies should address the question of 6 
interactions between all four (and additional) polymorphisms in dopamine system genes in a 7 
larger infant cohort. 8 
Despite the likely effect of both frontal and subcortical mechanisms in the reported 9 
results, it is not possible to establish the exact neural substrate of this interaction from the 10 
current data. Previous studies have found additive genetic effects of the DAT1 3’ VNTR and 11 
COMT Val158Met polymorphisms on neural efficiency in the frontal cortex (Bertolino et al., 12 
2006; Caldú et al., 2007). However, an interaction between the two polymorphisms has not 13 
previously been reported (though see Prata et al., 2009, for a recent study which found an 14 
epistatic effect in the parietal cortex). Further research using neuroimaging data will help 15 
elucidate the potential role of the frontal cortex and the striatum in these genotype effects. 16 
The current study constitutes a snapshot in time at 9 months of age. Future studies over a 17 
wider age range may help elucidate which patterns of Freeze-Frame performance are adaptive 18 
throughout infancy and early childhood, and how these patterns relate to polymorphisms in 19 
dopamine system genes. Some progress has already been made towards this at the behavioral 20 
level in the work by Holmboe and colleagues (2008) where performance indices on early 21 
frontal cortex tasks showed both positive and negative associations with later performance. 22 
Nevertheless, an important conclusion to be drawn from the results of the present study is that 23 
polymorphisms in dopamine system genes play an important role already in infancy. Previous 24 
studies have found effects of the DRD4 48-bp VNTR on temperament and relatively broad 25 
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aspects of attention in infancy (Auerbach et al., 1999; Auerbach, Benjamin, Faroy, Geller, & 1 
Ebstein, 2001; Auerbach, Faroy, Ebstein, Kahana, & Levine, 2001; Ebstein et al., 1998; 2 
Laucht et al., 2006; Sheese et al., 2007). The current study adds to this evidence by showing 3 
that the COMT Val158Met polymorphism, which is thought to play an important role 4 
specifically in the frontal cortex, affects performance on a simple saccadic inhibition task in 5 
infancy. 6 
In conclusion, the results of the present study further validate the Freeze-Frame task, and 7 
demonstrate that variation in dopamine neurotransmission in the frontal cortex and associated 8 
subcortical structures can have an impact on infant attention already at 9 months of age. The 9 
exact neural substrate and developmental course of these genotypic differences is a fruitful 10 
area for future research. This research holds the promise of deepening our understanding of 11 
the genetic underpinnings of individual differences in the important functions mediated by 12 
the frontal cortex from an early age. 13 
 14 
15 
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Table 1. 1 
Genotype frequencies in the total sample and the Caucasian subsample (percentages in 2 
brackets). 3 
Polymorphism Genotype Total Caucasian Grouping 
DRD4 48-bp VNTR 2/3 2 (2.0) 2 (2.5) 7- 
 2/4 10 (9.8) 9 (11.4) 7- 
 2/7 8 (7.8) 4 (5.1) 7+ 
 3/4 8 (7.8) 6 (7.6) 7- 
 3/7 2 (2.0) 2 (2.5) 7+ 
 4/4 48 (47.1) 36 (45.6) 7- 
 4/5 2 (2.0) 0 (0.0) 7- 
 4/7 21 (20.6) 19 (24.1) 7+ 
 4/8 1 (1.0) 1 (1.3) 7+ 
 7+ 32 (31.4) 26 (32.9)  
COMT Val158Met Met/Met 28 (27.5) 19 (24.1) Met/Met 
 Val/Met 47 (46.1) 37 (46.8) Val/Met 
 Val/Val 27 (26.5) 23 (29.1) Val/Val 
DRD2 Taq1A A1/A1 4 (3.9) 4 (5.1) A1+ 
 A1/A2 29 (28.4) 20 (25.3) A1+ 
 A2/A2 69 (67.6) 55 (69.6) A1- 
 A1+ 33 (32.4) 24 (30.4)  
DAT1 3’ VNTR 3/10 1 (1.0) 0 (0.0) Non-10/10 
 7/10 1 (1.0) 0 (0.0) Non-10/10 
 9/9 4 (3.9) 3 (3.8) Non-10/10 
 9/10 35 (34.3) 30 (38.0) Non-10/10 
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 10/10 60 (58.8) 45 (57.0) 10/10 
 10/11 1 (1.0) 1 (1.3) Non-10/10 
 Non-10/10 42 (41.2) 34 (43.0)  
Total N  102 79  
 1 
Note. Only data from infants who calibrated in the Freeze-Frame task are included in the 2 
table (data from infants who did not calibrate could not be used in the analyses). All 3 
polymorphisms except the DRD4 48-bp VNTR polymorphism conformed to Hardy-4 
Weinberg equilibrium: DRD4 48-bp VNTR: χ2 = 12.95, df = 6, p = .044 (all participants); χ2 5 
= 5.80, df = 6, p = .45 (Caucasians only). COMT Val158Met: χ2 = 0.63, df = 1, p = .43 (all 6 
participants); χ2 = 0.29, df = 1, p = .59 (Caucasians only). DRD2 Taq1A: χ2 = 0.18, df = 1, p = 7 
.67 (all participants); χ2 = 1.37, df = 1, p = .24 (Caucasians only). DAT1 3’ VNTR: χ2 = 0.16, 8 
df = 1, p = .69 (all participants); χ2 = 0.54, df = 1, p = .46 (Caucasians only). 9 
10 
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Table 2. 1 
Descriptive statistics for the proportion of looks to the distractors across phases and trial 2 
types in the Freeze-Frame task. 3 
 Mean SD 
Boring, Phase 1 .69 .22 
Boring, Phase 2 .42 .28 
Boring, Phase 3 .40 .24 
Boring, Phase 4* .39 .25 
Boring, Total .48 .17 
Interesting, Phase 1 .45 .25 
Interesting, Phase 2 .19 .19 
Interesting, Phase 3 .13 .16 
Interesting, Phase 4* .11 .15 
Interesting, Total .22 .14 
Note. *Only infants in Cohort 2 completed 4 phases. 4 
5 
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Figure Caption 1 
Figure 1. The effect of the COMT Val158Met and DAT1 3’ VNTR polymorphisms on Freeze-2 
Frame performance. Error bars indicate the 95% confidence interval of the mean. 3 
a, The mean proportion of looks to the distractors in the boring and interesting Freeze-Frame 4 
trials in the three COMT Val158Met genotype groups in the Caucasian subsample (Met/Met, n 5 
= 19; Val/Met, n = 37; Val/Val, n = 23); the asterisk (*) indicates a significant difference 6 
from the Met/Met group at p < .01. 7 
b, The mean proportion of looks to the distractors in the boring and interesting Freeze-Frame 8 
trials in the DAT1 10/10 and non-10/10 genotype groups (10/10, n = 60; non-10/10, n = 42); 9 
the overall difference between the two genotype groups (across trial types) was significant at 10 
p < .05. 11 
c, The effect of the COMT Val158Met polymorphism on the mean proportion of looks to the 12 
distractors in the interesting Freeze-Frame trials in the two DAT1 genotype groups (10/10 + 13 
Met/Met, n = 19; 10/10 + Val/Met, n = 26; 10/10 + Val/Val, n = 15; non-10/10 + Met/Met, n 14 
= 9; non-10/10 + Val/Met, n = 21; non-10/10 + Val/Val, n = 12); the asterisk (*) indicates a 15 
significant difference from the Met/Met group at p < .01 within the non-10/10 group, and the 16 
triangle (▲) indicates a significant difference at p < .01 between the Val/Met group in the 17 
non-10/10 group compared to the Val/Met group in the 10/10 group. 18 
